Publikationer 2012

1. A method for estimation of plasma albumin concentration from the buffering properties of whole blood. Rees SE, Diemer T, Kristensen SR. J Crit Care 2012;27(5):534.e1-6.
2. Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism : a post-translational mosaicism for heparin binding mutations. Martinez-Martinez I, Navarro-Fernández J, Østergaard A, Gutierrez-Gallego R, Padilla J, Bohdan N, Minano A, Pascual C, Martinez C , de la Morena-Barrio ME, Aguila S, Pedersen S, Kristensen SR, Vicente V, Corral J. Blood 2012;120(4):900-4.
3. Body mass index and thromboembolism in children with hematological malignancies. Tuckuviene R, Christensen AL, Chan AK, Athale U. Pediatr Blood Cancer 2012;59(2):320-2.
4. Calculating acid-base and oxygenation status during COPD exacerbation using mathematically arterialised venous blood. Rees SE, Rychwicka-Kielek BA, Andersen BF, Bibi R, Pedersen JF, Weinreich UM et al. Clinical Chemistry and Laboratory Medicine. 2012;50(12):2149-2154
5. CD4 lymphocyte dynamics in Tanzanian pulmonary tuberculosis patients with and without HIV co-infection. Andersen AB, Range NS, Changalucha J, Praygod G, Kidola J, Faurholt-Jepsen D, Krarup HB, Grewal H, Friis H. BMC Infect Dis 2012;12(1):66.
6. Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members. Thomassen M, Blanco A, Montagna M, Hansen TV, Pedersen IS, Gutiérrez-Enríquez S, Menéndez M, Fachal L, Santamariña M, Steffensen AY, Jønson L, Agata S, Whiley P, Tognazzo S, Tornero E, Jensen UB, Balmaña J, Kruse TA, Goldgar DE, Lazaro C, Diez O, Spurdle AB, Vega A. Breast Cancer Res Treat 2012;132(3):1009-23.
7. Comparison of the transcutaneous bilirubinometers BiliCheck and Minolta JM-103 in preterm neonates. Ebbesen F, Vandborg PK, Trydal T. Acta Paediatr 2012;101(11):1128-33.
8. ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. Spurdle AB, Healey S, Devereau A, Hogervorst FB, Monteiro AN, Nathanson KL, Radice P, Stoppa-Lyonnet D, Tavtigian SV, Wappenschmidt B, Couch FJ, Goldgar DE, [on behalf of ENIGMA] . Hum Mutat 2012;33(1):2-7.
9. Highly sensitive troponin T in patients with acute ischemic stroke. Jensen JK, Ueland T, Aukrust P, Antonsen L, Kristensen SR, Januzzi JL, Ravkilde J. Eur Neurol 2012;68(5):287-93.
10. Extracorporeal cardiopulmonary support may be an efficient rescue of patients after massive pulmonary embolism. An experimental porcine study. Kjærgaard B, Rasmussen BS, de Neergaard S, Rasmussen LH, Kristensen SR. Thromb Res 2012;129(4):e147-51.
11. Hepatitis C prevalence in Denmark -an estimate based on multiple national registers. Christensen PB, Hay G, Jepsen P, Omland LH, Just SA, Krarup HB, Weis N, Obel N, Cowan S. BMC Infect Dis 2012;12(1):178.
12. High recovery of cell-free methylated DNA based on a rapid bisulfite-treatment protocol. Pedersen IS, Krarup HB, Thorlacius-Ussing O, Madsen PH. BMC Mol Biol 2012;13(1):12-e8.
13. Infant, obstetrical and maternal characteristics associated with thromboembolism in infancy: a nationwide population-based case-control study. Tuckuviene R, Christensen AL, Helgestad J, Hundborg HH, Kristensen SR, Johnsen SP. Arch Dis Child Fetal Neonatal Ed 2012;97(6):F417-22.
14. Interaction between Blood type, smoking and factor V Leiden Mutation and risk of Venous Thromboembolism: A Danish Case-Cohort Study.El-Galaly T, Kristensen SR, Overvad K, Steffensen R, Tjønneland A, Severinsen MT. J Thromb Haemost 2012;10(10):2191-3.
15. Lack of consistency between two commercial ELISAs and against an in-house ELISA for the detection of CD36 in human plasma. Lykkeboe S, Larsen AL, Handberg A. Clin Chem Lab Med 2012;50(6):1071-4.
16. Liver cancer and non-hodgkin lymphoma in hepatitis C virus-infected patients: results from the danvir cohort study. Omland LH, Jepsen P, Krarup HB, Christensen PB, Weis N, Nielsen L, Obel N, Sørensen HT, Stuver SO, [On behalf of the DANVIR Cohort Study] . Int J Cancer 2012;130(10):2310-7.
17. Long-term follow-up among Danish transfusion recipients identified in the national hepatitis C lookback. Just SA, Grau K, Georgsen J, Weis N, Cowan S, Grønbæk K, Krarup HB, Christensen PB, [The Danish HCV Lookback Group] . Transfusion 2012;52(3):582-8.
18. MSH6 Mutations are Frequent in Hereditary Nonpolyposis Colorectal Cancer Families With Normal pMSH6 Expression as Detected by Immunohistochemistry. Okkels H, Larsen KL, Thorlacius-Ussing O, Vyberg M, Lindebjerg J, Sunde L, Bernstein I, Klarskov L, Holck S, Krarup HB. Appl Immunohistochem Mol Morphol 2012;20(5):470-7.
19. Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C. Christensen PB, Krarup HB, Laursen AL, Madsen PH, Pedersen C, Schlichting P, Orholm M, Ring-Larsen H, Bukh J, Krogsgaard K. Scand J Gastroenterol 2012;8-9(47):1115-9.
20. Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients. Liani R, Halvorsen B, Sestili S, Handberg A, Santilli F, Vazzana N, Formoso G, Aukrust P, Davi G. Free Radic Biol Med 2012;52(8):1318-24.
21. Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. Handberg A, Højlund K, Gastaldelli A, Flyvbjerg A, Dekker JM, Petrie J, Piatti P, Beck-Nielsen H, [the RISC Investigators] . J Intern Med 2012;271(3):294-304.
22. Population-based comparative epidemiological survey of hepatitis B, D, and C among Inuit migrated to Denmark and in high endemic Greenland. Rex KF, Krarup HB, Laurberg P, Andersen S. Scand J Gastroenterol 2012;47(6):692-701.
23. The role of diabetes co-morbidity for tuberculosis treatment outcomes: a prospective cohort study from mwanza, Tanzania. Faurholt-Jepsen D, Range N, Praygod G, Kidola J, Faurholt-Jepsen M, Aabye MG, Changalucha J, Christensen DL, Martinussen T, Krarup HB, Witte DR, Andersen AB, Friis H. BMC Infect Dis 2012;12(1):165.
24. The role of diabetes on the clinical manifestations of pulmonary tuberculosis. Faurholt-Jepsen D, Range N, Praygod G, Jeremiah K, Faurholt-Jepsen M, Aabye MG, Changalucha J, Christensen DL, Krarup HB, Witte DR, Andersen AB, Friis H. Trop Med Int Health 2012;17(7):877-83.
25. Treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection - Danish national guidelines 2011. Christensen PB, Clausen MR, Krarup HB, Laursen AL, Schlichting P, Weis N. Dan Med J 2012;59(6):C4465.

Bidrag til videnskabelig bog/antologi